Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease

[SupportiveMom]

In children newly diagnosed with comparably severe CD, early monotherapy with anti-TNFα produced better overall clinical and growth outcomes at 1 year than early monotherapy with an immunomodulator. Further data will be required to best identify children most likely to benefit from early treatment with anti-TNFα therapy.

http://www.ncbi.nlm.nih.gov/pubmed/24162032

Video: https://www.youtube.com/watch?v=Niu5L-7lC5c